Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| N6-methyladenosine modification of OIP5-AS1 promotes glycolysis, tumorigenesis, and metastasis of gastric cancer by inhibiting Trim21-mediated hnRNPA1 ubiquitination and degradation. | Gastric Cancer | 2024 | 37897508 | PubTator, text mining | PubMed |
| IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment. | Genes Dis | 2024 | 37692485 | PubTator, text mining | PubMed |
| UCA1 Inhibits NKG2D-mediated Cytotoxicity of NK Cells to Breast Cancer. | Curr Cancer Drug Targets | 2024 | 37076962 | PubTator, text mining | PubMed |
| The importance of cancer-associated fibroblasts in targeted therapies and drug resistance in breast cancer. | Front Oncol | 2023 | 38273859 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs (lncRNAs) in Heart Failure: A Comprehensive Review. | Noncoding RNA | 2023 | 38250803 | PubTator, text mining | PubMed |
| Interplay between lncRNA/miRNA and Wnt/ß-catenin signaling in brain cancer tumorigenesis. | EXCLI J | 2023 | 38204968 | PubTator, text mining | PubMed |
| Non-Coding RNAs as Key Regulators in Lung Cancer. | Int J Mol Sci | 2023 | 38203731 | PubTator, text mining | PubMed |
| CRISPR/Cas9 as a New Antiviral Strategy for Treating Hepatitis Viral Infections. | Int J Mol Sci | 2023 | 38203503 | PubTator, text mining | PubMed |
| YTHDF1 in Tumor Cell Metabolism: An Updated Review. | Molecules | 2023 | 38202722 | PubTator, text mining | PubMed |
| Expression of 3q Oncogene SEC62 Predicts Survival in Head and Neck Squamous Cell Carcinoma Patients Treated with Primary Chemoradiation. | Cancers (Basel) | 2023 | 38201525 | PubTator, text mining | PubMed |
| Lymph node metastasis-related lncRNA GAS6-AS1 facilitates the progression of esophageal squamous cell carcinoma. | J Gastrointest Oncol | 2023 | 38196547 | PubTator, text mining | PubMed |
| Establishment and validation of a prognostic immune-related lncRNA risk model for acute myeloid leukemia. | Transl Cancer Res | 2023 | 38192996 | PubTator, text mining | PubMed |
| Expanding the horizon of EV-RNAs: LncRNAs in EVs as biomarkers for disease pathways. | Extracell Vesicle | 2023 | 38188000 | PubTator, text mining | PubMed |
| LncRNAs in non-small cell lung cancer: novel diagnostic and prognostic biomarkers. | Front Mol Biosci | 2023 | 38152110 | PubTator, text mining | PubMed |
| A Critical Interpretive Synthesis of the Role of Arecoline in Oral Carcinogenesis: Is the Local Cholinergic Axis a Missing Link in Disease Pathophysiology? | Pharmaceuticals (Basel) | 2023 | 38139811 | PubTator, text mining | PubMed |
| Non-Coding RNAs and the Development of Chemoresistance to Docetaxel in Prostate Cancer: Regulatory Interactions and Approaches Based on Machine Learning Methods. | Life (Basel) | 2023 | 38137905 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Disulfidptosis-Related LncRNAs in Molecular Classification, Immune Microenvironment Characterization and Prognosis of Gastric Cancer. | Biomedicines | 2023 | 38137387 | PubTator, text mining | PubMed |
| Exosomal Cargo in Ovarian Cancer Dissemination. | Curr Issues Mol Biol | 2023 | 38132461 | PubTator, text mining | PubMed |
| Cancer susceptibility 18 positively regulates NUAK Family Kinase 1 expression to promote migration and invasion via sponging of miR-5586-5p in cervical cancer cells. | Int J Immunopathol Pharmacol | 2023 | 38131232 | PubTator, text mining | PubMed |
| New understandings of the genetic regulatory relationship between non-coding RNAs and m6A modification. | Front Genet | 2023 | 38125749 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=9